Device Trial Radar · NCT04595201
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,000
Actual
Start
Oct 13, 2020
Primary completion
Sep 1, 2026
Study completion Sep 2, 2026
Sponsor
- Lead sponsor
- Sequenom, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Integrated Genetics
- First posted
- Oct 20, 2020
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
Summary
As written by the sponsor on the registry.
To obtain pregnancy outcome data from patients screened for fetal genetic status using non-invasive pregnancy testing (NIPT).
Conditions
- Pregnancy
Interventions
NIPTDevice
Non-invasive pregnancy testing
Primary outcomes
What the sponsor says the trial is designed to measure.
- NIPT clinical outcome performanceTime frame: 9 months
- NIPT clinical outcome performanceTime frame: 9 months
- NIPT clinical outcome performanceTime frame: 9 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Integrated Genetics
Westborough, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.